Evidence map›Paper›PMID 37064312›Full record

ArticleHealth science reports2023

Willingness to receive COVID-19 booster dose and its associated factors in Ghana: A cross-sectional study.

Rebecca Peniel Storph, Mainprice Akuoko Essuman, Ruth Duku-Takyi, Albert Akotua, Samuel Asante, Richard Armah, Irene Esi Donkoh, Prince Anim Addo

Abstract read
In one paragraph

Article in Health science reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rebecca Peniel StorphLaboratory Department Cape Coast Teaching Hospital Cape Coast Ghana.ORCID 0000-0002-6800-7837
Mainprice Akuoko EssumanDepartment of Medical Laboratory Science, School of Allied Health Sciences, College of Health and Allied Sciences University of Cape Coast Cape Coast Ghana.ORCID 0000-0002-4641-2647
Ruth Duku-TakyiDepartment of Medical Laboratory Technology Accra Technical University Accra Ghana.
Albert AkotuaICT Department University Practice Senior High School Cape Coast Ghana.
Samuel AsanteLaboratory Department Cape Coast Teaching Hospital Cape Coast Ghana.
Richard ArmahDepartment of Medical Laboratory Science, School of Allied Health Sciences, College of Health and Allied Sciences University of Cape Coast Cape Coast Ghana.
Irene Esi DonkohDepartment of Medical Laboratory Science, School of Allied Health Sciences, College of Health and Allied Sciences University of Cape Coast Cape Coast Ghana.
Prince Anim AddoLaboratory Department Kasoa Polyclinic Kasoa Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: The COVID-19 booster dose has been cited as an important supplement for the control of the COVID-19 pandemic due to reports of waning immunity among fully vaccinated persons. Determining factors that would affect its acceptability is necessary for initiating successful vaccination programs. In this study, we aimed to evaluate the factors associated with the acceptability of the COVID-19 booster dose in Ghana. Methods: We conducted an online cross-sectional survey among the public. A self-administered questionnaire was used to collect information on demographic characteristics, willingness to vaccinate, perceptions toward COVID-19 vaccines, and trust in the government. Participants provided reasons and sources of advice that may affect their willingness to accept a booster dose. Using IBM SPSS and R Statistic; descriptive, univariate, and multivariate analyses were performed. Results: Out of 812 respondents, 375 (46.2%) intended to accept the booster dose. Individuals who were males (adjusted odds ratio [aOR] 1.63, 95% confidence interval [CI] 1.07-2.48), had previously received other forms of vaccination twice (aOR 1.96, 95% CI 1.07-3.57) or in most years (aOR 2.51, 95% CI 1.38-4.57), tested positive for COVID-19 (aOR 3.46, 95% CI 1.23-10.52), have high trust in government (aOR=1.77, 95% CI: 1.15-2.74) and had positive perceptions regarding COVID-19 vaccines (OR = 14.24, 95% CI: 9.28-22.44) were more likely to accept a booster dose. Experiencing side effects from the primer dose (aOR 0.12, 95% CI 0.08-0.18) was associated with reduced acceptance. Concerns about vaccine safety and efficacy were the common reasons impeding willingness, while advice from health professionals would be the most considered. Conclusion: Low intention to accept the booster dose which is associated with a range of factors including the perception of vaccines and trust in the government, is a cause for concern. Thus, more effort would have to be taken through education and policy interventions to increase booster vaccine acceptability.

Indexed as

booster doseCOVID‐19Ghanavaccinevaccine acceptancewillingness

Identifiers

PMID37064312
PMCPMC10090037

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.